BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Aurobindo Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524804
ISIN Demat
INE406A01037
Book Value (Rs)
391.1437121
NSE Symbol
AUROPHARMA
Divident Yield %
0.26
Market Cap
(Rs In Cr.)
89,957
P/E (TTM)
37.04
EPS (TTM)
41.81
Face Value
(Rs)
1
Back
Aurobindo Pharma receives US FTC approval for acquisition of Lannett business
19-Jun-26   Hrs IST

Aurobindo Pharma announced that its wholly owned subsidiary, Aurobindo Pharma USA Inc. has received the approval from US Federal Trade Commission (FTC) for the acquisition of 100% of membership interest in Lannett Company LLC from LANNETT SELLER HOLDCO, INC.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)